A detailed history of Arcadia Investment Management Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Arcadia Investment Management Corp holds 3,000 shares of FOLD stock, worth $28,980. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,000
Holding current value
$28,980
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$9.55 - $12.09 $28,650 - $36,270
3,000 New
3,000 $32,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.71B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.